Comparative Effectiveness of Two Tiotropium Formulations: A Retrospective Cohort Study-Reference-Cited by-同舟云学术

Comparative Effectiveness of Two Tiotropium Formulations: A Retrospective Cohort Study

Published:2018-09-03 Issue:5 Volume:15 Page:418-423
ISSN:1541-2555
Container-title:COPD: Journal of Chronic Obstructive Pulmonary Disease
language:en
Short-container-title:COPD: Journal of Chronic Obstructive Pulmonary Disease

Author:

Spila-Alegiani Stefania¹,Trotta Francesco²,Da Cas Roberto¹,Rossi Mariangela³,Venegoni Mauro⁴,Traversa Giuseppe¹

Affiliation:

1. Pharmacoepidemiology Unit, National Center for Drug Research and Evaluation, National Institute of Health (ISS), Rome, Italy;

2. Italian Medicines Agency (AIFA), Rome, Italy;

3. Unit for Pharmaceutical Governance, General Directorate for Health, Perugia, Italy;

4. Pharmacology Institute, University of Verona, Verona, Italy

Funder

Umbria Regional Health Authority.

Publisher

Informa UK Limited

Subject

Pulmonary and Respiratory Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15412555.2018.1554032

Reference14 articles.

1. Clinical effectiveness of the Respimat® inhaler device in managing chronic obstructive pulmonary disease: evidence when compared with other handheld inhaler devices

2. Tiotropium Respimat® Soft Mist™ Inhaler: A Review of Its Use in Chronic Obstructive Pulmonary Disease

3. European Medicines Agency. Pharmacovigilance Risk Assessment Committee (PRAC). Minutes of the meeting- 7–10 January 2013 [accessed 2018 Apr 24]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Minutes/2013/02/WC500139251.pdf.

4. Tiotropium Respimat Inhaler and the Risk of Death in COPD

5. Use of tiotropium Respimat Soft Mist InhalerversusHandiHaler and mortality in patients with COPD

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisión narrativa de la terapia inhalatoria en la EPOC;Medicina de Familia. SEMERGEN;2021-09

Healthcare Resource Utilization, Exacerbations, and Readmissions Among Medicare Patients with Chronic Obstructive Pulmonary Disease After Long-Acting Muscarinic Antagonist Therapy Initiation with Soft Mist versus Dry Powder Inhalers

;International Journal of Chronic Obstructive Pulmonary Disease;2020-12

3. Global initiative gold and national recommendations on the management of patients with chronic obstructive pulmonary disease (COPD): the place of double bronchodilation;Medical Council;2019-12-08